Ventyx Biosciences Inc (NASDAQ: VTYX) on Monday, plunged -3.53% from the previous trading day, before settling in for the closing price of $3.12. Within the past 52 weeks, VTYX’s price has moved between $1.67 and $11.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 36.44%. With a float of $53.33 million, this company’s outstanding shares have now reached $70.67 million.
Let’s determine the extent of company efficiency that accounts for 80 employees. In terms of profitability, gross margin is -4.74%, operating margin of -15258.18%, and the pretax margin is -14175.09%.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 24.58%, while institutional ownership is 63.94%. The most recent insider transaction that took place on Nov 25 ’24, was worth 524,944. In this transaction CEO AND PRESIDENT of this company bought 261,752 shares at a rate of $2.01, taking the stock ownership to the 2,175,028 shares. Before that another transaction happened on Nov 22 ’24, when Company’s CEO AND PRESIDENT bought 238,248 for $1.83, making the entire transaction worth $434,946. This insider now owns 1,913,276 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 36.44% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 23.52 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.03 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Looking closely at Ventyx Biosciences Inc (NASDAQ: VTYX), its last 5-days average volume was 2.67 million, which is a jump from its year-to-date volume of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 75.58%. Additionally, its Average True Range was 0.25.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 77.91%, which indicates a significant increase from 77.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.62% in the past 14 days, which was higher than the 91.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $3.51. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $3.23. Second resistance stands at $3.45. The third major resistance level sits at $3.60. If the price goes on to break the first support level at $2.87, it is likely to go to the next support level at $2.72. Now, if the price goes above the second support level, the third support stands at $2.50.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 212.84 million based on 70,711K outstanding shares. Right now, sales total 0 K and income totals -192,960 K. The company made 0 K in profit during its latest quarter, and -35,250 K in sales during its previous quarter.
